BIODESIX INC

Profile

Company Names

BIODESIX INC

Addresses

2970 WILDERNESS PLACE, SUITE 100, BOULDER, CO 80301

520 ZANG STREET, SUITE 213, BROOMFIELD, CO 80021

Phone Numbers

303-417-0500

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$175,380,419.00

Number of Funding Rounds:

20
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
20
2019-12-10 
$16,000,000.00 
$31,000,000.00 
$15,000,000.00 
 
19
2019-08-08 
$4,902,500.00 
$10,000,000.00 
$5,097,500.00 
 
18
2018-10-10 
$17,511,736.00 
$27,524,500.00 
$10,012,764.00 
Equity 
17
2018-06-30 
$7,987,428.00 
$7,987,428.00 
$0.00 
Equity 
16
2018-04-13 
$5,282,162.00 
$10,282,858.00 
$5,000,696.00 
 
15
2018-02-23 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
14
2017-04-12 
$13,165,482.00 
$25,332,143.00 
$12,166,661.00 
Equity 
13
2016-11-09 
$5,121,632.00 
$15,700,000.00 
$10,578,368.00 
 
12
2016-07-13 
$6,114,729.00 
$7,208,382.00 
$1,093,653.00 
Equity 
11
2016-01-29 
$17,756,512.00 
$22,202,324.00 
$4,445,812.00 
Equity 
10
2015-09-25 
$8,609,000.00 
$20,000,000.00 
$11,391,000.00 
 
9
2015-06-09 
$10,390,000.00 
$15,148,000.00 
$4,758,000.00 
Equity 
8
2014-12-31 
$11,285,000.00 
$18,158,000.00 
$6,873,000.00 
Equity 
7
2013-11-21 
$14,407,686.00 
$16,362,306.00 
$1,954,620.00 
Equity 
6
2013-10-08 
$4,011,400.00 
$4,011,400.00 
$0.00 
 
5
2013-03-28 
$7,313,440.00 
$14,666,668.00 
$7,353,228.00 
Equity 
4
2012-08-21 
$5,685,500.00 
$13,400,000.00 
$7,714,500.00 
Equity 
3
2011-06-21 
$10,000,000.00 
$20,000,000.00 
$10,000,000.00 
Equity 
2
2010-10-15 
$3,536,232.00 
$7,069,791.00 
$3,533,559.00 
Equity 
1
2009-09-15 
$4,799,980.00 
$10,000,000.00 
$5,200,020.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
BERESFORD, PH.D. 
EXECUTIVE OFFICER
WENDY 
 
BLOSSER 
EXECUTIVE OFFICER
DAVID 
 
BRUNEL 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
CAWTHORN 
DIRECTOR
BOBBI 
 
COFFIN 
EXECUTIVE OFFICER
ROBIN 
 
COWIE 
EXECUTIVE OFFICER
LIZ 
 
FLIEGELMAN 
EXECUTIVE OFFICER
JEAN 
 
FRANCHI 
DIRECTOR
ROBERT 
 
GEORGANTAS 
EXECUTIVE OFFICER
SCOTT 
 
HUTTON 
EXECUTIVE OFFICER, DIRECTOR
HANY 
 
MASSARANY 
DIRECTOR
JOHN 
 
PATIENCE 
DIRECTOR
GARY 
 
PESTANO, PH.D. 
EXECUTIVE OFFICER
JIM 
 
PURVIS 
EXECUTIVE OFFICER
HEINRICH 
 
RODER 
EXECUTIVE OFFICER, DIRECTOR
HEINRICH 
 
RODER, D.PHIL 
EXECUTIVE OFFICER
HEINRICH 
 
RODER, D.PHIL. 
EXECUTIVE OFFICER
FRANK 
 
RONCHETTI 
EXECUTIVE OFFICER
MATT 
 
STAUFFER 
EXECUTIVE OFFICER
LINDA 
 
TRAYLOR, PH.D. 
EXECUTIVE OFFICER
CHARLES 
 
WATTS 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
 
2019-12-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2019-12-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2019-08-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2018-04-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2016-11-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2015-09-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2013-10-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#